Status:
TERMINATED
Cross Linking for Treatment of Corneal Infection
Lead Sponsor:
Price Vision Group
Collaborating Sponsors:
Cornea Research Foundation of America
Conditions:
Infectious Keratitis
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
This study is comparing 45 minute and 30 minute treatment durations with the UVX corneal cross linking system to treat corneal infections.
Eligibility Criteria
Inclusion
- diagnosis of infectious keratitis
Exclusion
- corneal ulcer that has perforated
- corneal ulcer that has produced a descemetocele
- women who are pregnant or breastfeeding
- patients who are immunocompromised or unwilling or unable to comply with a medication regimen
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00912509
Start Date
May 1 2009
End Date
June 1 2013
Last Update
November 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Price Vision Group
Indianapolis, Indiana, United States, 46260